Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$9,650,614
+$2,758,778 QoQ
Shares Held
8,046
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#1,277
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. LLY ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
|
3,608 | $565,445 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,650,614 | 8,046 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,891,836 | 7,493 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $7,146,622 | 6,650 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,104,470 | 6,690 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $4,059,792 | 5,208 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,786,797 | 4,585 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,769,936 | 3,588 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,019,943 | 2,280 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,885,001 | 2,082 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,049,468 | 1,349 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $743,223 | 1,275 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $671,412 | 1,250 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $637,812 | 1,360 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $463,960 | 1,351 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $512,176 | 1,400 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $412,917 | 1,277 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $430,253 | 1,327 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $363,403 | 1,269 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $350,523 | 1,269 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $271,483 | 1,175 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $291,490 | 1,270 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $240,063 | 1,285 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $205,984 | 1,220 | Shares | Sole | 2021-02-01 | |
| No filing history on record for this holder in this stock. | ||||||